← Back to all trials
Recruiting
NCT07140757
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
Conditions: Low Risk, Papillary Thyroid Cancer, Radiofrequency Ablation
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 50
Sponsor: M.D. Anderson Cancer Center
Location: MD Anderson Cancer Center Houston Texas
Summary
To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.
Eligibility Criteria
Eligibility Criteria
1. Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC
2. Participant is over 18 years and is either not a surgical candidate or has declined surgery.
3. Capable and willing to provide written informed consent
4. Participant has one of the following diagnoses:
* Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment,
* Biopsy-proven indeterminate nodules (AUS or follicular neoplasm)
* Papillary thyroid carcinoma (PTC) without metastasis
* Locally recurrent thyroid cancer (\< 2 cm).
Exclusion Criteria
1. Participants meeting any of the following criteria will be excluded:
2. Participants considered unsuitable for RFA by the treating physician
Source: ClinicalTrials.gov (NCT07140757). StuddyBuddy aggregates publicly available trial information.